- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | SciBase Holding AB Q3 Sales Increase | 2 | RTTNews | ||
| Do | SciBase: Interim report | 339 | PR Newswire | SciBase: Interim report
January 1 - September 30, 2026STOCKHOLM, Nov. 12, 2026 /PRNewswire/ --
The third quarter in figuresNet sales were TSEK 14,621 (10,339), +41%, cleared for currency effects... ► Artikel lesen | |
| Do | SCIBASE HOLDING AB: Interim report | 4 | Cision News | ||
| 15.10. | SciBase has secured first US payer coverage with major insurance company, aims for global lead in non-invasive skin assessment | 483 | PR Newswire | SciBase has secured first US payer coverage with major insurance company, aims for global lead in non-invasive skin assessmentSTOCKHOLM, Oct. 15, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase")... ► Artikel lesen | |
| 15.10. | SciBase's EIS Technology Selected as Primary Endpoint in NIH Skin Barrier Study | 632 | PR Newswire | STOCKHOLM, Oct. 15, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that a new study will be... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 09.10. | Scibase Holding AB: SciBase's rights issue registered, conversion of BTA into shares | 490 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") announces that the rights issue of shares of approximately SEK 57.5 million resolved by the Board of Directors on 3 September 2026, the outcome... ► Artikel lesen | |
| 07.10. | SCIBASE HOLDING AB: Recalculation of warrants of series TO 2 following rights issue | 2 | Cision News | ||
| 07.10. | Scibase Holding AB: SciBase resolves on a set-off issue of shares to the guarantor in connection with the completed rights issue | 215 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") has today, on 7 October 2026, resolved on a set-off issue of 60,000 shares to Bergs Securities AB ("Bergs Securities") in its capacity as guarantor... ► Artikel lesen | |
| 01.10. | Scibase Holding AB: SciBase announces outcome of rights issue of shares | 232 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") today, on 1 October 2026, announces the outcome of the rights issue of shares of approximately SEK 57.5 million resolved by the Board of Directors... ► Artikel lesen | |
| 25.09. | SciBase announces confirmed guarantee commitment in connection with ongoing rights issue | 533 | PR Newswire | STOCKHOLM, Sept. 25, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") announces that Bergs Securities AB ("Bergs Securities") has today, on 25 September 2026, fulfilled... ► Artikel lesen | |
| 15.09. | Listing of subscription rights and paid subscription shares of Scibase Holding AB | 362 | GlobeNewswire | With effect from September 16, 2026, the subscription rights in Scibase Holding AB will be traded on First North Growth Market. Trading will continue up until and including September 24,... ► Artikel lesen | |
| 15.09. | SciBase: Updated first day of trading in subscription rights and paid-up subscribed shares | 777 | PR Newswire | STOCKHOLM, Sept. 15, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces that the Company has resolved to update the first day of trading in subscription... ► Artikel lesen | |
| 15.09. | SCIBASE HOLDING AB: Updated first day of trading in subscription rights and paid-up subscribed shares | 4 | Cision News | ||
| 14.09. | SciBase publishes information document regarding the rights issue | 529 | PR Newswire | STOCKHOLM, Sept. 14, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") is publishing an information document in connection with the rights issue... ► Artikel lesen | |
| 14.09. | Scibase Holding AB: SciBase publishes information document regarding the rights issue | 276 | GlobeNewswire (Europe) | The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") is publishing an information document in connection with the rights issue of shares of approximately SEK 58 million (the... ► Artikel lesen | |
| 08.09. | SciBase receives additional order from Castle Biosciences, advancing the collaboration | 472 | PR Newswire | STOCKHOLM, Sept. 8, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has... ► Artikel lesen | |
| 08.09. | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.09.2026 | 527 | Xetra Newsboard | Das Instrument 7M8 SE0003273531 ECORUB AB B EQUITY wird cum Kapitalmassnahme gehandelt am 08.09.2026 und ex Kapitalmassnahme am 09.09.2026 The instrument 7M8 SE0003273531 ECORUB AB B EQUITY is traded... ► Artikel lesen | |
| 03.09. | SciBase Resolves On A Rights Issue Of Shares Of Approximately Sek 58 Million | 595 | PR Newswire | STOCKHOLM, Sept. 3, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, pursuant to the authorisation granted by the annual general... ► Artikel lesen | |
| 19.08. | SciBase: Interim report | 449 | PR Newswire | STOCKHOLM, Aug. 19, 2026 /PRNewswire/ --
January 1 - June 30, 2026The second quarter in figures Net sales were TSEK 15,308 (8,791), +74%, cleared for currency effects +84%. ... ► Artikel lesen | |
| 28.07. | SciBase announces changes in senior management | 509 | PR Newswire | STOCKHOLM, July 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced that Pia Renaudin... ► Artikel lesen |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,067 | -3,75 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 40,180 | +0,45 % | Bear of the Day: Boston Scientific (BSX) | ||
| PAUL HARTMANN | 187,00 | -1,84 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 12,040 | +1,82 % | Sysmex Corporation H1 Profit Drops | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) released earnings for first half that Dropped, from the same period last yearThe company's bottom line came in at JPY17.933 billion, or JPY29.47... ► Artikel lesen | |
| ADDLIFE | 16,280 | -1,33 % | AddLife AB: AddLife acquires MoonSurge | AddLife has acquired MoonSurge, Importação e Exportação de Material Médico, LDA, a leading Portuguese distributor of high-quality medical devices for advanced surgery. MoonSurge will become an independent... ► Artikel lesen | |
| EMBECTA | 5,790 | -0,38 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ENOVIS | 25,400 | +1,60 % | Enovis stock price target reaffirmed at $42 by BTIG on growth | ||
| PULMONX | 2,620 | 0,00 % | Pulmonx auf der Stifel 2026 Healthcare Conference: Strategische Neuausrichtung gewinnt an Dynamik | ||
| SI-BONE | 21,600 | 0,00 % | SI-BONE, Inc.: SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx, Extending Its Compromised Bone Franchise Beyond the Pelvis | SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised... ► Artikel lesen | |
| KOOTH | 2,180 | +0,93 % | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | ||
| PEIJIA MEDICAL | 0,414 | -3,27 % | Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth | SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| LIFECARE ASA | 0,039 | 0,00 % | Lifecare ASA Q3 Loss Narrows | ||
| BACTIGUARD | 1,160 | 0,00 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2026 | Accelerating performance validates our partnership model
Third quarter 2026 (July - September)Total revenue amounted to SEK 58.4 (48.4) million, an increase of SEK 10.0 million corresponding to 20.6%.Net... ► Artikel lesen | |
| PHC HOLDINGS | 6,800 | -4,23 % | PHC Holdings Q2 FY2026 slides: profit surges 87% on diabetes strength | ||
| FRESENIUS MEDICAL CARE | 40,100 | +1,36 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 38 auf 37,50 Euro gesenkt und die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen |
SCIBASE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,860 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.